Replies to post #242488 on Biotech Values

[DewDiligence]

ITOS acquired by Tang Capital for $10.047/sh +CVR—a 2% discount to Friday’s close (excluding the CVR)—and a 45% discount to ITOS’ 2020 IPO price (#msg-157131985):

https://finance.yahoo.com/news/iteos-therapeutics-enters-agreement-acquired-112900130.html